Uwe Platzbecker (@uweplatzbecker) 's Twitter Profile
Uwe Platzbecker

@uweplatzbecker

ID: 1044625666656915456

linkhttp://www.d-mds.de calendar_today25-09-2018 16:32:21

40 Tweet

459 Followers

34 Following

Uwe Platzbecker (@uweplatzbecker) 's Twitter Profile Photo

Just saw a patient with hem cancer in the outpatient department. He was very hesitant to receive Covid vaccination because „what the internet states makes me worry about safety and efficacy“. This is not a single case!

Jon Cohen (@sciencecohen) 's Twitter Profile Photo

As the old scientific saw goes, you don't need a control group if there's a talking dog. That green line = talking dog. Yes, blue line is a control, and difference is striking, but everyone knows hospitals are buckling. The green line screams the vaccinated aren't the problem.

As the old scientific saw goes, you don't need a control group if there's a talking dog. That green line = talking dog. Yes, blue line is a control, and difference is striking, but everyone knows hospitals are buckling. The green line screams the vaccinated aren't the problem.
Expertscape: Your Source For Medical Experts (@daily_experts) 's Twitter Profile Photo

During Blood Cancer Awareness Month (September 2021), we congratulate Dr. Uwe Platzbecker [UKL_Leipzig] of Universitatsklinikum Leipzig -- Recognized as an Expertscape World Expert in Myeloid Leukemia. expertscape.com/ex/leukemia%2C…

During Blood Cancer Awareness Month (September 2021), we congratulate Dr. Uwe Platzbecker [UKL_Leipzig] of Universitatsklinikum Leipzig -- Recognized as an Expertscape World Expert in Myeloid Leukemia.
expertscape.com/ex/leukemia%2C…
Uwe Platzbecker (@uweplatzbecker) 's Twitter Profile Photo

Today: An important date in my life. Thanks to the courage of East Germans in 1989 I can attend the German-Swiss-Austrian conference in former West-Berlin today ! Humbleness. bundesregierung.de/breg-de/themen…

Munich Leukemia Laboratory (@leukaemielabor) 's Twitter Profile Photo

It was a great event with fascinating talks - the future path in hematology seems brightly lit. Looking forward to the update in 2022!

Guilherme Perini, MD (@guiperinimd) 's Twitter Profile Photo

#PeriniPicks for #ASH21 No.2 - CNS prophylaxis again and again... ash.confex.com/ash/2021/webpr… No difference in CNS relapses in HD-MTx vs nothing in high risk patients, including subgroup of adrenal/renal or testicular involvement. Keeps getting hard to defend CNS proph...

ESH (Haematology) (@eshaematology) 's Twitter Profile Photo

📣#ESHMDS2022 ONE MONTH LEFT TO SUBMIT YOUR ABSTRACTS! Submit yours now ➡ bit.ly/3mKmCpT 8th Translational Research Conference #MYELODYSPLASTIC #SYNDROMES Mandelieu-La Napoule, France - April 7-10, 2022 Chairs: FENAUX Pierre Uwe Platzbecker Mikkael A. Sekeres MD, MS #ESHCONFERENCES

📣#ESHMDS2022 ONE MONTH LEFT TO SUBMIT YOUR ABSTRACTS!
Submit yours now ➡ bit.ly/3mKmCpT
8th Translational Research Conference #MYELODYSPLASTIC #SYNDROMES
Mandelieu-La Napoule, France - April 7-10, 2022
Chairs: <a href="/FenauxP/">FENAUX Pierre</a> <a href="/UwePlatzbecker/">Uwe Platzbecker</a> <a href="/MikkaelSekeres/">Mikkael A. Sekeres MD, MS</a>
#ESHCONFERENCES
ESH (Haematology) (@eshaematology) 's Twitter Profile Photo

📣#ESHMDS2022 2 WEEKS LEFT TO SUBMIT YOUR ABSTRACTS! Click to submit yours➡ bit.ly/3mKmCpT 8th Translational Research Conference #MYELODYSPLASTIC #SYNDROMES Mandelieu-La Napoule, France - April 7-10, 2022 Chairs: FENAUX Pierre Uwe Platzbecker Mikkael A. Sekeres MD, MS #ESHCONFERENCES

📣#ESHMDS2022 2 WEEKS LEFT TO SUBMIT YOUR ABSTRACTS!
Click to submit yours➡ bit.ly/3mKmCpT
8th Translational Research Conference #MYELODYSPLASTIC #SYNDROMES
Mandelieu-La Napoule, France - April 7-10, 2022
Chairs: <a href="/FenauxP/">FENAUX Pierre</a> <a href="/UwePlatzbecker/">Uwe Platzbecker</a> <a href="/MikkaelSekeres/">Mikkael A. Sekeres MD, MS</a>
#ESHCONFERENCES
ESH (Haematology) (@eshaematology) 's Twitter Profile Photo

📣 #ESHAL2022 E-CONFERENCE: FREE REGISTRATION! ➡ bit.ly/3tpKZgo 3rd How to Diagnose & Treat #ACUTE #LEUKAEMIAS March 10-13, 2022 Chairs: Dombret Hervé, Gert Ossenkoppele, Jorge Sierra, Wendy Stock SUBMIT YOUR ABSTRACT ➡ bit.ly/3b3fkqt #ESHCONFERENCES #LEUSM

📣 #ESHAL2022 E-CONFERENCE: FREE REGISTRATION! ➡ bit.ly/3tpKZgo
3rd How to Diagnose &amp; Treat #ACUTE #LEUKAEMIAS March 10-13, 2022
Chairs: <a href="/DombretHerve/">Dombret Hervé</a>, Gert Ossenkoppele, Jorge Sierra, Wendy Stock
SUBMIT YOUR ABSTRACT ➡ bit.ly/3b3fkqt
#ESHCONFERENCES #LEUSM
Frontiers - Oncology (@frontoncology) 's Twitter Profile Photo

📄 New article: #CaseReport: Large Granular Lymphocyte Leukemia (LGLL)—A Case Series of Challenging Presentations 👨‍⚕️👩‍⚕️ Natali Pflug et al. Read here 👉 fro.ntiers.in/dnG4 Uwe Platzbecker Madlen Jentzsch Universität zu Köln UNIVERSITÄT LEIPZIG #LGLL #LEUsm #Leukemia #HemOnc

ESH (Haematology) (@eshaematology) 's Twitter Profile Photo

📣#ESHMDS2022: EXTENDED DEADLINE FOR ABSTRACTS: FEBRUARY 6th! SUBMIT NOW ➡ bit.ly/3tOcroe 8th Translational Research Conference #MYELODYSPLASTIC #SYNDROMES Mandelieu-La Napoule, France - April 7-10, 2022 Chairs: FENAUX Pierre Uwe Platzbecker Mikkael A. Sekeres MD, MS #ESHCONFERENCES

📣#ESHMDS2022: EXTENDED DEADLINE FOR ABSTRACTS: FEBRUARY 6th!
SUBMIT NOW ➡ bit.ly/3tOcroe
8th Translational Research Conference #MYELODYSPLASTIC #SYNDROMES
Mandelieu-La Napoule, France - April 7-10, 2022
Chairs: <a href="/FenauxP/">FENAUX Pierre</a> <a href="/UwePlatzbecker/">Uwe Platzbecker</a> <a href="/MikkaelSekeres/">Mikkael A. Sekeres MD, MS</a>
#ESHCONFERENCES
Australasian Leukaemia & Lymphoma Group (ALLG) (@allgtrials) 's Twitter Profile Photo

Uwe Platzbecker & Judith Trotman #EHA2023. Uwe recruited the 1st patient to Impress trial, another ALLG international collaboration! (Phase II study evaluating efficacy & safety of Imetelstat in Patients with HR myelodysplastic Syndromes or AML failing HMA-based therapy)

<a href="/UwePlatzbecker/">Uwe Platzbecker</a> &amp; <a href="/JudithTrotman1/">Judith Trotman</a> #EHA2023. Uwe recruited the 1st patient to Impress trial, another ALLG international collaboration! (Phase II study evaluating efficacy &amp; safety of Imetelstat in Patients with HR myelodysplastic Syndromes or AML failing HMA-based therapy)